Organon (OGN) Tops Q3 EPS by 23c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/9/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Morgan Stanley Reiterates Overweight Rating on Rocket Lab USA (RKLB), Bull Case Raised to $293
- GameStop stockholders approve share count increase to 2.5 billion
- Crude Inventory Rose 3 Million Barrels Last Week - EIA
- AI bubble fears mount as Zuckerberg admits agent delays and Burry shorts sector
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
Organon Reports Results for the Third Quarter Ended September 30, 2021
November 11, 2021 6:31 AM ESTThird quarter 2021 revenue of $1,600 million Net income from continuing operations of $323 million, or $1.27 per diluted share; Adjusted net income from continuing operations of $424Â million, or $1.67 per diluted share Adjusted EBITDA of $636Â million Board of Directors declares quarterly dividend of $0.28 per share Financial guidance affirmed;Â ranges for revenue and Adjusted EBITDA margin, narrowed Executing on business development; announces acquisition of Forendo Pharma
JERSEY CITY, N.J.--(BUSINESS WIRE)-- Organon (NYSE: OGN) (the company), today announced its results for the third quarter and year to... More
